Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00874094 · ClinicalTrials.gov registry record · Phase 1
Pilot Evaluation of Platelet Rich Fibrin Matrix (PRFM) for the Correction of Nasolabial Folds
A Phase 1 study of Nasolabial Folds, sponsored by The New York Eye & Ear Infirmary.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT00874094: Completed Phase 1 study of Nasolabial Folds, sponsored by The New York Eye & Ear Infirmary.
NCT00874094 is a Phase 1 study of Nasolabial Folds that has completed, run by The New York Eye & Ear Infirmary. The registered enrollment target is 15 participants, below the 63-participant average among 4 other Nasolabial Folds trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00874094, a Phase 1 study of Nasolabial Folds, has completed, sponsored by The New York Eye & Ear Infirmary.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Platelets are a component of blood, which contain factors which can enhance wound healing. This study proposes to evaluate the clinical response of laugh lines treated with a concentrated preparation of the subject's own platelets injected into or under the skin by taking serial photographs of the subject's face over a 12 week period. Also, the same preparation will be injected into or under the skin of the arm near the elbows, and serial biopsies will be taken over a 12 week period.
Primary Outcome
Difference in wrinkle assessment score, values ranging from 0 (least noticeable) to 5 ( most noticeable) (scores on a scale)between pre-treatment and 12 weeks post-treatment.
Conditions Studied
Interventions
- BIOLOGICAL Platelet rich fibrin matrix
Study Locations (1)
New York
- The New York Eye & Ear Infirmary- Otolaryngology Faculty practice satellite - Chappaqua
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-07 |
| Phase | Phase 1 |
What the finished NCT00874094 record still lists
NCT00874094 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 63-participant average among 4 other Nasolabial Folds trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Nasolabial Folds appearing as the primary indexed condition, and to 1 intervention - of which Platelet rich fibrin matrix is the first listed.
NCT00874094 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00874094 about?
NCT00874094 is a clinical study titled "Pilot Evaluation of Platelet Rich Fibrin Matrix (PRFM) for the Correction of Nasolabial Folds". Platelets are a component of blood, which contain factors which can enhance wound healing. This study proposes to evaluate the clinical response of laugh lines treated with a concentrated preparation of the subject's own platelets injected into or under the skin by taking serial photographs of the s...
What is the current status of trial NCT00874094?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2008-04. Estimated completion is 2009-07.
What conditions does trial NCT00874094 study?
This clinical trial studies the following conditions: Nasolabial Folds.
What interventions are being tested in trial NCT00874094?
The interventions under investigation include: Platelet rich fibrin matrix (BIOLOGICAL).
Who is sponsoring clinical trial NCT00874094?
This trial is sponsored by The New York Eye & Ear Infirmary, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00874094 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nasolabial Folds
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers
COMPLETED · Phase 1
-
Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolabial Folds
RECRUITING · NA
-
Evaluation of Pain With Lidocaine-Mixed Radiesse® Injectable Dermal Filler
COMPLETED · Phase 4
-
Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia